Compare AARD & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AARD | RFM |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | 40 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.7M | 89.3M |
| IPO Year | N/A | 2019 |
| Metric | AARD | RFM |
|---|---|---|
| Price | $4.87 | $14.58 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $15.29 | N/A |
| AVG Volume (30 Days) | ★ 123.0K | 10.7K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.35 | $13.68 |
| 52 Week High | $17.94 | $14.90 |
| Indicator | AARD | RFM |
|---|---|---|
| Relative Strength Index (RSI) | 61.92 | 53.14 |
| Support Level | $4.81 | $14.19 |
| Resistance Level | $5.83 | $14.69 |
| Average True Range (ATR) | 0.34 | 0.12 |
| MACD | 0.15 | -0.01 |
| Stochastic Oscillator | 83.43 | 62.96 |
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.